Del. Jury Says NanoString Owes $31M In 10x Patent Spat

By Lauren Berg · November 17, 2023, 11:41 PM EST

A Delaware federal jury on Friday determined that Seattle-based NanoString Technologies Inc. willfully infringed several gene technology patents exclusively licensed to 10x Genomics and awarded more than $31 million in damages,...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Verdict

Case Information

Case Title

10X Genomics, Inc. et al v. Brucker Spatial Biology Inc. et al

Case Number

Court

Delaware

Nature of Suit

Patent

Date Filed

May 06, 2021

Recent Articles By Lauren

September 30, 2024
Takeda End Payors, Direct Buyers Win Antitrust Class Cert.
September 30, 2024
Bristol-Myers Beats Celgene Investors' Drug Delay Suit
September 27, 2024
9th Circ. Says Stem Cell Treatment Not Exempt From FDA Rule
August 30, 2024
McKesson, Others To Pay Benefit Plans $300M In Opioid Deal
August 23, 2024
NY Can't Sue Groups Over Abortion 'Reversal' Ads, For Now
August 21, 2024
Fed. Circ. Won't Rethink IP Safe Harbor Case
August 21, 2024
2nd Circ. Partly Revives Life Insurance Suit Against AXA
August 09, 2024
Takeda Should Face Certified Antitrust Classes, Judge Says
August 06, 2024
Henrietta Lacks' Family Sues Novartis, Viatris Over HeLa Cells
August 02, 2024
5th Circ. Upholds Challenge To Surprise Medical Billing Rule